UnitedHealth's lower-than-feared costs lift profit, shares
Reuters
Published Jul 14, 2023 05:59AM ET
Updated Jul 14, 2023 04:31PM ET
By Bhanvi Satija and Raghav Mahobe
(Reuters) -UnitedHealth Group's quarterly profit beat Wall Street estimates on Friday as a smaller-than-expected jump in medical costs allayed fears that a resumption in long-delayed surgical procedures would hit profit growth.
The company's results allowed investors to breathe a sigh of relief following a $60-billion wipeout in industry market value last month, after UnitedHealth (NYSE:UNH) raised alarms about rising costs.
Its shares ended up 7%, while rivals Humana (NYSE:HUM), Cigna (NYSE:CI) and Elevance Health closed 2% to 5% higher on Friday.
The results were a "welcome respite," after several weeks of pain for investors in health insurance companies, Stephens analyst Scott Fidel said in a note.
CFO John Rex said the company expects premiums for its 2024 Medicare Advantage plans would be priced to soften the blow from an increase in non-urgent surgeries.
Health insurers' costs have stayed low in recent years as pandemic-driven restrictions led to extended delays in elective procedures such as hip and knee replacements, especially among older adults at higher risk of COVID.
UnitedHealth last month said Medicare-eligible adults had started opting for these procedures as COVID risks had receded, leading to a spike in costs.
In June, Humana had warned of a jump in its medical expenses this year, noting similar concerns.
UnitedHealth's quarterly medical loss ratio - the percentage of its spending on claims compared to premiums collected - was 83.2%, compared with analysts' expectations of 83.4%, according to Refinitiv.
The healthcare conglomerate said it expects medical costs for the third quarter to be "a little bit lower" compared with second-quarter expenses.
UnitedHealth had raised the lower end of its annual adjusted profit forecast to $24.70, from $24.50 per share in April.
UnitedHealth's second-quarter profit of $6.14 per share topped expectations of $5.99.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.